Efficacité des veinoglobulines dans le scléromyxœdème d'Arndt-Gottron

Since Arndt-Gottron scleromyxedema is a rare disease, no standardized treatment has been yet established. The combination of minimal adverse effects and real efficacy makes IVIG an interesting alternative treatment for this disease.